The DZL Scientific Advisory Board counsels the Board of Directors and the General Assembly on scientific and programmatic questions. It is made up of internationally acclaimed experts in the field of lung research. The 12 members of the Scientific Advisory Board are:
Chairman of the Scientific Advisory Board
Chief, Devision of Medicine-Pulmonary, Ernest S. Bazeley
Professor of Asthma and Related Disorders, Northwestern University Feinberg School of Medicine; USA
Head of Respiratory Medicine, Imperial College London; UK
Senior Vice President / Head of Research and Early Development Respiratory and Immunology Biopharmaceuticals R&D, AstraZeneca, UK
Professor of Respiratory Pharmacology, NHLI, Imperial College London, UK
Professor of Respiratory Cell and Molecular Biology, Center for Respiratory Research, University College London; UK
Distinguished Parker B. Francis Professor of Medicine, Harvard Medical School
Editor-in-Chief, New England Journal of Medicine; USA
Professor of Respiratory Medicine
Director Cystic Fibrosis Center
President of the European Cystic Fibrosis Society (ECFS), Centre for Infection and Immunity, Queen's University Belfast; IRL
Medical Director, Professorship for Pediatrics, Universitäts-Kinderspital beider Basel, CH
Division Chief, Pulmonary Allergy, and Critical Care Medicine
Director Vascular Medicine Institute, University of Pittsburgh Medical Center; USA
Director of the European Lung Foundation (ELF), Sheffield; UK
Holder of the Chair for Medical Informatics, Friedrich-Alexander-Universität Erlangen-Nürnberg
Chief Information Officer, Universitätsklinikum Erlangen
former Member of the Board of the German Society for Medical Informatics, Biometry and Epidemiology (GMDS); D
Deputy Director, National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH); USA
Akademien der Wissenschaften Schweiz, Cente Médical Universitaire, University of Geneva; CH
